Patury, C.B.; Santos, B.L.M.; Matos, A.L.C.; Slabi, J.; Gastalho, L.C.C.; Kaneto, C.M.
Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study. Biomolecules 2024, 14, 1580.
https://doi.org/10.3390/biom14121580
AMA Style
Patury CB, Santos BLM, Matos ALC, Slabi J, Gastalho LCC, Kaneto CM.
Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study. Biomolecules. 2024; 14(12):1580.
https://doi.org/10.3390/biom14121580
Chicago/Turabian Style
Patury, Carine Bispo, Brenda Luanny Maia Santos, Anna Lucia Carvalho Matos, José Slabi, Luciene Cristina Campos Gastalho, and Carla Martins Kaneto.
2024. "Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study" Biomolecules 14, no. 12: 1580.
https://doi.org/10.3390/biom14121580
APA Style
Patury, C. B., Santos, B. L. M., Matos, A. L. C., Slabi, J., Gastalho, L. C. C., & Kaneto, C. M.
(2024). Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study. Biomolecules, 14(12), 1580.
https://doi.org/10.3390/biom14121580
